Literature DB >> 20487817

Expression of A and B types of monoamine oxidase in neuroblastoma hybrid cells.

T Nagatsu1, T Nakano, T Kato, H Higashida.   

Abstract

Monoamine oxidase (MAO) activity towards kynuramine as substrate was measured in 6 hybrid cells derived by fusion of neuroblastoma and glioma, liver or brain cells, and was compared with that of parental or non-parental clones. Activities varied from the lowest level of less than 0.15 pmol/min/mg protein in a neuroblastoma clone NB2A to the highest level of 127 pmol/min/mg protein in NCB20 mouse neuroblastoma x Chinese hamster embryo brain hybrid cells. The relative proportions of A and B types of MAO activities were determined in homogenates of each cell line by inhibition curves with clorgyline and deprenyl. Although the A type activity was found in all cell lines measured, MAO A was predominant in 9 clones, except for NCB20 hybrid cells, N4G-B-a neuroblastoma x glioma hybrid cells, and G8-1 myoblast. The ratio of type A/type B activity in NCB20, N4G-B-a and G8-1 cells was 20/80, 75/25 and 95/5, respectively. The results suggest that NCB20 cells are highly enriched in MAO type B, and that the NCB20 cell is an excellent model for studying the type B activity found in the brain in vivo.

Entities:  

Year:  1981        PMID: 20487817     DOI: 10.1016/0197-0186(81)90032-2

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  2 in total

1.  Cyclic ADP-ribose as an endogenous inhibitor of the mTOR pathway downstream of dopamine receptors in the mouse striatum.

Authors:  Haruhiro Higashida; Shin-Ya Kamimura; Takeshi Inoue; Osamu Hori; Mohammad Saharul Islam; Olga Lopatina; Chiharu Tsuji
Journal:  J Neural Transm (Vienna)       Date:  2016-12-26       Impact factor: 3.575

2.  Bovine herpesvirus 4 infects differentiated neuronal cells in culture and establish persistent infection upon selection.

Authors:  Gaetano Donofrio; Giulio Grandi; Sandro Cavirani; Simone Taddei; Cesidio Flammini
Journal:  J Neurovirol       Date:  2004-04       Impact factor: 2.643

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.